The exact timing depends on your current dose, side effects, and how well you tolerated semaglutide
Communication: If you find you are accumulating extra medication, talk to your provider
Semaglutide on Liver and Cardiovascular Related Outcomes in Patients with MASLD/MASH, Obesity, and Type 2 Diabetes Mellitus: A Real-World Cohort Study Tuesday, October 28, 2025 | 9:00 AM 9:10 AM PDT | North Ballroom 120BC Author Insight from Basil Jalamneh, MD Whats new here and important for clinicians
We are here to help
When not able to use AID, sensor-augmented IPT with predictive low glucose suspend (IPT+PLGS) may be used in adults who are hypoglycemia prone to reduce frequency of hypoglycemic events and severe hypoglycemia [Grade B, Level 2] [75]
Therefore, these studies demonstrated that GLP-1RAs have an impact on preventing and stabilizing atherosclerotic vascular disease, which may translate into its protective effects against MACE in human subjects [59]